JP2023534576A5 - - Google Patents
Info
- Publication number
- JP2023534576A5 JP2023534576A5 JP2022557800A JP2022557800A JP2023534576A5 JP 2023534576 A5 JP2023534576 A5 JP 2023534576A5 JP 2022557800 A JP2022557800 A JP 2022557800A JP 2022557800 A JP2022557800 A JP 2022557800A JP 2023534576 A5 JP2023534576 A5 JP 2023534576A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- pharmaceutical composition
- weeks
- administered
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062993443P | 2020-03-23 | 2020-03-23 | |
| US62/993,443 | 2020-03-23 | ||
| US202063037783P | 2020-06-11 | 2020-06-11 | |
| US63/037,783 | 2020-06-11 | ||
| US202063061497P | 2020-08-05 | 2020-08-05 | |
| US63/061,497 | 2020-08-05 | ||
| US202063068593P | 2020-08-21 | 2020-08-21 | |
| US63/068,593 | 2020-08-21 | ||
| US17/084,957 US12187788B2 (en) | 2020-03-23 | 2020-10-30 | Methods for treating atopic dermatitis and related disorders |
| US17/084,957 | 2020-10-30 | ||
| AU2020260519A AU2020260519A1 (en) | 2020-03-23 | 2020-10-30 | Methods for treating atopic dermatitis and related disorders |
| AU2020260519 | 2020-10-30 | ||
| CA3097453 | 2020-10-30 | ||
| CA3097453A CA3097453A1 (en) | 2020-03-23 | 2020-10-30 | Methods for treating atopic dermatitis and related disorders |
| JP2020182046A JP2021147383A (ja) | 2020-03-23 | 2020-10-30 | アトピー性皮膚炎及び関連障害を処置するための方法 |
| JP2020182046 | 2020-10-30 | ||
| PCT/EP2021/057463 WO2021191220A1 (en) | 2020-03-23 | 2021-03-23 | Methods for treating atopic dermatitis and related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534576A JP2023534576A (ja) | 2023-08-10 |
| JP2023534576A5 true JP2023534576A5 (https=) | 2024-04-03 |
Family
ID=77890940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557800A Pending JP2023534576A (ja) | 2020-03-23 | 2021-03-23 | アトピー性皮膚炎及び関連する障害の治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230287099A1 (https=) |
| EP (1) | EP4126943B1 (https=) |
| JP (1) | JP2023534576A (https=) |
| KR (1) | KR20230004489A (https=) |
| IL (1) | IL296620A (https=) |
| WO (1) | WO2021191220A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| AU2006296399B2 (en) | 2005-09-30 | 2011-01-20 | Medimmune Limited | Interleukin-13 antibody composition |
| WO2017139290A1 (en) * | 2016-02-10 | 2017-08-17 | Medimmune, Llc | Tralokinumab delivery device |
| PT3528838T (pt) * | 2016-09-23 | 2023-09-04 | Hoffmann La Roche | Utilizações de antagonistas de il-13 para tratamento de dermatite atópica |
| BR112019018022A2 (pt) | 2017-03-01 | 2020-06-02 | Medimmune Limited | Formulações de anticorpos monoclonais |
-
2021
- 2021-03-23 KR KR1020227035768A patent/KR20230004489A/ko active Pending
- 2021-03-23 WO PCT/EP2021/057463 patent/WO2021191220A1/en not_active Ceased
- 2021-03-23 JP JP2022557800A patent/JP2023534576A/ja active Pending
- 2021-03-23 EP EP21716969.7A patent/EP4126943B1/en active Active
- 2021-03-23 IL IL296620A patent/IL296620A/en unknown
- 2021-03-23 US US17/913,483 patent/US20230287099A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017201201B2 (en) | Treatment for dermatological pathologies | |
| US11191831B2 (en) | Treatment of psychiatric conditions | |
| US20230303677A1 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| AU2013327498B2 (en) | Treatment of psychiatric conditions | |
| WO2019097493A1 (en) | Treating hidradenitis suppurativa with il-17 antagonists | |
| JP2022523530A5 (https=) | ||
| JP2023534576A5 (https=) | ||
| JP2024522620A5 (https=) | ||
| JP2023522971A (ja) | 呼吸器疾患の治療のための汎ｅｌｒ＋ｃｘｃケモカイン抗体 | |
| JP2022526493A5 (https=) | ||
| WO2018158741A1 (en) | Psoriasis disease modification following long-term treatment with an il-17 antagonist | |
| WO2024184333A1 (en) | Il-22r antibody for use in treating atopic dermatitis | |
| JP2024510744A5 (https=) | ||
| AU2020396455A1 (en) | Methods of treating lichen planus using Interleukin-17 (IL-17) antagonists |